IQVIA Holdings Inc. (NYSE:IQV) Shares Purchased by Heritage Investors Management Corp

Heritage Investors Management Corp boosted its holdings in IQVIA Holdings Inc. (NYSE:IQV) by 2.6% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 80,048 shares of the medical research company’s stock after buying an additional 2,025 shares during the quarter. Heritage Investors Management Corp’s holdings in IQVIA were worth $18,969,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in IQV. First Foundation Advisors raised its holdings in IQVIA by 3.8% in the 2nd quarter. First Foundation Advisors now owns 1,161 shares of the medical research company’s stock worth $245,000 after acquiring an additional 43 shares during the period. Team Hewins LLC increased its holdings in shares of IQVIA by 5.0% during the 1st quarter. Team Hewins LLC now owns 973 shares of the medical research company’s stock worth $246,000 after purchasing an additional 46 shares during the period. Invera Wealth Advisors LLC increased its holdings in shares of IQVIA by 0.3% during the 2nd quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company’s stock worth $3,183,000 after purchasing an additional 46 shares during the period. Covestor Ltd increased its holdings in shares of IQVIA by 45.3% during the 1st quarter. Covestor Ltd now owns 154 shares of the medical research company’s stock worth $39,000 after purchasing an additional 48 shares during the period. Finally, Oregon Public Employees Retirement Fund increased its holdings in shares of IQVIA by 0.3% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company’s stock worth $3,313,000 after purchasing an additional 48 shares during the period. Institutional investors and hedge funds own 89.62% of the company’s stock.

Insider Buying and Selling at IQVIA

In other news, insider Eric Sherbet sold 1,300 shares of the company’s stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the transaction, the insider now directly owns 19,536 shares in the company, valued at approximately $4,812,302.88. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

IQV has been the topic of several research reports. Robert W. Baird dropped their price objective on shares of IQVIA from $256.00 to $223.00 and set a “neutral” rating on the stock in a report on Friday. UBS Group boosted their price objective on shares of IQVIA from $295.00 to $300.00 and gave the stock a “buy” rating in a report on Tuesday, July 23rd. BTIG Research dropped their price objective on shares of IQVIA from $290.00 to $260.00 and set a “buy” rating on the stock in a report on Friday. Deutsche Bank Aktiengesellschaft decreased their target price on shares of IQVIA from $270.00 to $265.00 and set a “buy” rating on the stock in a research report on Friday. Finally, The Goldman Sachs Group decreased their target price on shares of IQVIA from $280.00 to $250.00 and set a “buy” rating on the stock in a research report on Friday. Four equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, IQVIA has a consensus rating of “Moderate Buy” and a consensus target price of $261.56.

IQVIA Price Performance

NYSE:IQV traded up $0.31 on Tuesday, reaching $210.50. The stock had a trading volume of 26,190 shares, compared to its average volume of 1,087,178. The company has a market capitalization of $38.21 billion, a P/E ratio of 27.58, a price-to-earnings-growth ratio of 2.07 and a beta of 1.51. IQVIA Holdings Inc. has a 1-year low of $190.20 and a 1-year high of $261.73. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.76. The stock has a fifty day moving average price of $233.55 and a 200-day moving average price of $229.64.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.